Overall mortality |
Follow-up (years), mean±SD | 3.23±2.44 | 3.3±2.47 | |
Event number, n (%) | 1465 (5.9) | 285 (2.3) | |
Cumulative incidence (%) | 15.6 (95% CI 14.6 to 16.5) | 6.7 (95% CI 5.7 to 7.7) | <0.001 |
End-stage renal disease |
Follow-up (years), mean±SD | 3.22±2.44 | 3.3±2.47 | |
Event number, n (%) | 105 (0.4) | 8 (0.1) | |
Competing mortality, n (%) | 1434 (5.8) | 283 (2.3) | |
Cumulative incidence (%) | 1.32 (95% CI 1.01 to 1.64) | 0.15 (95% CI 0.04 to 0.26) | <0.001 |
Acute coronary syndrome |
Follow-up (years), mean±SD | 3.2±2.43 | 3.29±2.46 | |
Event number, n (%) | 269 (1.1) | 104 (0.8) | |
Competing mortality, n (%) | 1442 (5.8) | 279 (2.3) | |
Cumulative incidence (%) | 2.96 (95% CI 2.46 to 3.45) | 2.21 (95% CI 1.7 to 2.71) | 0.027 |
Ischaemic stroke |
Follow-up (years), mean±SD | 3.21±2.43 | 3.29±2.46 | |
Event number, n (%) | 186 (0.8) | 57 (0.5) | |
Competing mortality, n (%) | 1427 (5.8) | 280 (2.3) | |
Cumulative incidence (%) | 1.76 (95% CI 1.44 to 2.08) | 1.31 (95% CI 0.85 to 1.77) | 0.001 |
Catastrophic autoimmune disease |
Follow-up (years), mean±SD | 3.22±2.44 | 3.3±2.47 | |
Event number, n (%) | 63 (0.3) | 33 (0.3) | |
Competing mortality, n (%) | 1461 (5.9) | 281 (2.3) | |
Cumulative incidence (%) | 0.49 (95% CI 0.35 to 0.63) | 0.57 (95% CI 0.31 to 0.83) | 0.816 |